These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17158441)

  • 21. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
    Crespo N; Illnait J; Más R; Fernández L; Fernández J; Castaño G
    Int J Clin Pharmacol Res; 1999; 19(4):117-27. PubMed ID: 10939029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant use of policosanol and beta-blockers in older patients.
    Castaño G; Mas R; Gámez R; Fernández J; Illnait J; Fernández L; Mendoza S; Mesa M; Gutiérrez JA; López E
    Int J Clin Pharmacol Res; 2004; 24(2-3):65-77. PubMed ID: 15689053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of effect of sugar cane policosanol on plasma cholesterol in Golden Syrian hamsters.
    Kassis AN; Marinangeli CP; Jain D; Ebine N; Jones PJ
    Atherosclerosis; 2007 Sep; 194(1):153-8. PubMed ID: 17123537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.
    Castaño G; Más R; Fernández L; Illnait J; Mendoza S; Gámez R; Fernández J; Mesa M
    Drugs Exp Clin Res; 2005; 31 Suppl():31-44. PubMed ID: 16444910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
    Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent.
    Gouni-Berthold I; Berthold HK
    Am Heart J; 2002 Feb; 143(2):356-65. PubMed ID: 11835043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia.
    Castaño G; Fernández L; Mas R; Illnait J; Fernández J; Mesa M; Alvarez E; Lezcay M
    Int J Clin Pharmacol Res; 2002; 22(2):55-66. PubMed ID: 12503776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials.
    Gong J; Qin X; Yuan F; Hu M; Chen G; Fang K; Wang D; Jiang S; Li J; Zhao Y; Huang Z; Dong H; Lu F
    Mol Nutr Food Res; 2018 Jan; 62(1):. PubMed ID: 28730734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study.
    Castaño G; Más R; Fernández J; López E; Illnait J; Fernández L; Mesa M
    Curr Ther Res Clin Exp; 2003 Sep; 64(8):522-37. PubMed ID: 24944402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.
    Gutierrez MJ; Rosenberg NL; Macdougall DE; Hanselman JC; Margulies JR; Strange P; Milad MA; McBride SJ; Newton RS
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):676-83. PubMed ID: 24385236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of successive dose increases of policosanol on the lipid profile of patients with type II hypercholesterolaemia and tolerability to treatment.
    Pons P; Rodríguez M; Robaina C; Illnait J; Más R; Fernández L; Fernández JC
    Int J Clin Pharmacol Res; 1994; 14(1):27-33. PubMed ID: 7927958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LDL-cholesterol-lowering effect of a dietary supplement with plant extracts in subjects with moderate hypercholesterolemia.
    Ogier N; Amiot MJ; Georgé S; Maillot M; Mallmann C; Maraninchi M; Morange S; Lescuyer JF; Peltier SL; Cardinault N
    Eur J Nutr; 2013 Mar; 52(2):547-57. PubMed ID: 22527287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol-lowering effects of policosanol in rabbits.
    Arruzazabala ML; Carbajal D; Mas R; Molina V; Valdes S; Laguna A
    Biol Res; 1994; 27(3-4):205-8. PubMed ID: 8728832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A combined natural supplement lowers LDL cholesterol in subjects with moderate untreated hypercholesterolemia: a randomized placebo-controlled trial.
    Barrat E; Zaïr Y; Ogier N; Housez B; Vergara C; Maudet C; Lescuyer JF; Bard JM; Carpentier YA; Cazaubiel M; Peltier SL
    Int J Food Sci Nutr; 2013 Nov; 64(7):882-9. PubMed ID: 23815518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial.
    Ballantyne CM; Houri J; Notarbartolo A; Melani L; Lipka LJ; Suresh R; Sun S; LeBeaut AP; Sager PT; Veltri EP;
    Circulation; 2003 May; 107(19):2409-15. PubMed ID: 12719279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consumption of Cuban Policosanol Improves Blood Pressure and Lipid Profile via Enhancement of HDL Functionality in Healthy Women Subjects: Randomized, Double-Blinded, and Placebo-Controlled Study.
    Cho KH; Kim SJ; Yadav D; Kim JY; Kim JR
    Oxid Med Cell Longev; 2018; 2018():4809525. PubMed ID: 29854085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors.
    Más R; Castaño G; Illnait J; Fernández L; Fernández J; Alemán C; Pontigas V; Lescay M
    Clin Pharmacol Ther; 1999 Apr; 65(4):439-47. PubMed ID: 10223782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The whey fermentation product malleable protein matrix decreases triglyceride concentrations in subjects with hypercholesterolemia: a randomized placebo-controlled trial.
    Berthold HK; Schulte DM; Lapointe JF; Lemieux P; Krone W; Gouni-Berthold I
    J Dairy Sci; 2011 Feb; 94(2):589-601. PubMed ID: 21257028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [EFFICIENCY OF CONCOMITANT USE OF POLICOSANOL AND ROSUVASTATIN IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE AND MODERATE HEPATIC DYSFUNCTION].
    Solomenchuk TM; Vosukh V; Bedzay A; Koval VG; Chepka IM; Trotsko VV
    Lik Sprava; 2015; (7-8):29-37. PubMed ID: 27491147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resin from the mukul myrrh tree, guggul, can it be used for treating hypercholesterolemia? A randomized, controlled study.
    Nohr LA; Rasmussen LB; Straand J
    Complement Ther Med; 2009 Jan; 17(1):16-22. PubMed ID: 19114224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.